BRCA1 Mutation

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

BRCA1 Mutation is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

2

clinical trials

Active, not recruiting2 · 100%

Clinical Trials

Trial Activity

Influenza Vaccine Study in BRCA1 or BRCA2 Carriers

Active, not recruiting·AAbramson Cancer Center at Penn Medicine·N/A·NCT04499534·50 enrolled

Randomized Controlled Trial of Accessible Online Genetic Services for Cascade Testing for BRCA Mutation Carriers Versus Usual Care in a Clinic Setting

Active, not recruiting·WWeill Medical College of Cornell University·Preclinical·NCT04613440·524 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)